Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes

2 May 2017

Abstract excerpt

Abstract B lymphocytes play a key role in type 1 diabetes (T1D) development by serving as a subset of APCs preferentially supporting the expansion of autoreactive pathogenic T cells. As a result of their pathogenic importance, B lymphocyte–targeted therapies have received considerable interest as potential T1D interventions. Unfortunately, the B lymphocyte–directed T1D interventions tested to date failed to halt...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes and associated disorders
Share to Diabetes Management and Research
Share to Pancreatic function and diabetes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28461573
DOI: 10.4049/jimmunol.1700024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B LymphocytesPMID 28461573Read ↗

Attenuating homologous recombination stimulates an AID-induced antileukemic effectSemantic proximity Read ↗

Disrupted RNA editing in beta cells mimics early-stage type 1 diabetesSemantic proximity Read ↗

Applications of Genome-Editing Technologies for Type 1 DiabetesSemantic proximity Read ↗

Autoimmune CD8+ T cells in type 1 diabetes: from single-cell RNA sequencing to T-cell receptor redirectionSemantic proximity Read ↗

CD38 defines a therapeutically targetable pathogenic T cell population for precision immunotherapy in autoimmune diabetesSemantic proximity Read ↗

mTOR Activation Underlies Enhanced B Cell Proliferation and Autoimmunity in PrkcdG510S/G510S MiceSemantic proximity Read ↗

Dclre1c-Mutation-Induced Immunocompromised Mice Are a Novel Model for Human Xenograft Research.Semantic proximity Read ↗

Small Molecule Inhibitors of Activation-Induced Deaminase Decrease Class Switch Recombination in B CellsSemantic proximity Read ↗

Class-switch recombination: after the dawn of AID.Semantic proximity Read ↗

Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes.Semantic proximity Read ↗

B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.Semantic proximity Read ↗

HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic MiceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.